Related Experiment Video
Updated: Jun 23, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure
A Georgi1, M Schneemann, K Tintelnot
1Department of Medicine, University Hospital Zurich, Zurich, Switzerland.
Insights
A rare case of severe meningoencephalitis caused by Cryptococcus gattii infection in an immunocompetent individual is presented. This infection developed 13 months after exposure, highlighting the potential for delayed onset and severe neurological complications.
Area of Science:
- Infectious Diseases
- Mycology
- Neurology
Background:
- Cryptococcus gattii is an emerging fungal pathogen causing meningoencephalitis, particularly in immunocompetent individuals.
- Vancouver Island, Canada, is an endemic region for Cryptococcus gattii.
- Delayed onset of cryptococcal meningoencephalitis can occur even in immunocompetent hosts.
Observation:
- A 53-year-old immunocompetent female developed severe meningoencephalitis 13 months after exposure on Vancouver Island.
- Diagnosis was confirmed by cerebrospinal fluid (CSF) India-ink staining, latex agglutination, and culture.
- Species identification of Cryptococcus gattii was achieved through phenotypic and molecular methods.
Findings:
- Initial fluconazole therapy was ineffective, necessitating a switch to amphotericin B and flucytosine.
- Subsequent treatment involved high-dose fluconazole and amphotericin B.
- Despite prolonged hospitalization (132 days) and CSF drainage, the patient showed only slow clinical improvement.
Implications:
- This case underscores the importance of considering Cryptococcus gattii in unexplained meningoencephalitis, even with delayed presentation.
- Aggressive and combination antifungal therapy, alongside supportive care, is crucial for managing severe cases.
- Further research is needed to understand the pathogenesis and optimize treatment strategies for Cryptococcus gattii meningoencephalitis.
Abstract:
A 53-year old immunocompetent Swiss female is described who developed severe meningoencephalitis due to infection with Cryptococcus gattii 13 months following exposure on Vancouver Island, Canada. Diagnosis was based on cerebrospinal fluid (CSF) examination, i.e., positive India-ink staining, positive latex particle agglutination, and positive culture. Species identification was performed by growth on L-canavanine-glycine-bromthymol blue medium and by sequencing of the intergenic and internal transcribed spacer regions of the rRNA genes. After initial therapy with fluconazole by which the patient did not improve, therapy was changed to amphotericin B and flucytosine and later to high-dose fluconazole and amphotericin B. Despite long-term treatment and external drainage of the CSF, the patient's condition improved only slowly. The patient was discharged after 132 days of hospitalization.
Related Concept Videos
Cryptococcal Meningitis
Rabies
Toxoplasmosis
Encephalitis l: Introduction
Cytomegalovirus Disease
Rocky Mountain Spotted Fever
